Background Up to 50% of patients undergoing allogenic stem cell transplantation or bone
marrow transplantation (BMT) can develop acute or chronic graft versus host disease …

Background: Cutaneous chronic graft versus host disease (GVHD) is a severe complication
following allogeneic stem cell (PBSCT) and bone marrow transplantation (BMT) …

Background Chronic graft‐versus‐host disease is a severe complication of allogeneic stem
cell and bone marrow transplantation. First‐line immunosuppressive agents, such as …

The potentially beneficial effect of 8-methoxypsoralen and ultraviolet A (PUVA) irradiation for
treatment of drug-resistant cutaneous manifestations of graft-versus-host disease led us to …

For several years, psoralen and UV-A light (PUVA) therapy has been used in the treatment
of chronic graft-versus-host disease (GvHD) following allogeneic bone marrow …

Introduction and objectives Cutaneous chronic graft-vs-host disease (GVHD) is a common
complication of hematopoietic stem cell transplantation. Phototherapy is a therapeutic option …

Graft-versus-host disease is a frequent complication of allogenic bone marrow
transplantation. Approximately 10% of patients suffering from chronic graft-versus-host …

Acute graft-versus-host disease (aGVHD) is a frequent and major complication after
allogeneic stem cell transplantation. For many years psoralen and ultraviolet (UV)-A light …

Psoralen plus ultraviolet A irradiation (PUVA) has immunomodulatory effects and is used to
treat a variety of immune-mediated dermatologic diseases. We administered PUVA to 103 …

Graft-versus-host disease (GVHD) is a frequent complication occurring after allogeneic
hematopoietic stem cell transplantation. It can be classified as acute and chronic GVHD …